logo
Select company
Select metric
Ticker Information

Ticker

ATRA

Company Name

ATARA BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ATARA BIOTHERAPEUTICS INC - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ATRA - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ -35.04M$ 5.79M0%
3/31/2025$ -55.07M$ -15.64M0%
12/31/2024$ -97.28M$ -85.4M0%
9/30/2024$ -90.54M$ -133.16M0%
6/30/2024$ -110.87M$ -181.05M0%
3/31/2024$ -98.31M$ -233.11M0%
12/31/2023$ -99.23M$ -276.13M0%
9/30/2023$ -50.84M$ -290.25M0%
6/30/2023$ 7.45M$ -304.54M-4085.62%
3/31/2023$ 64.96M$ -214.97M-330.92%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ATARA BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) ROE stands at -85.84%.
  • Over the past 5 years, ATARA BIOTHERAPEUTICS INC's average ROE has been -461.21%.
  • The median ROE for ATARA BIOTHERAPEUTICS INC during this period was -113.72%
  • ATARA BIOTHERAPEUTICS INC reached its highest ROE over the past 5 years at -66.32%.
  • The lowest ROE recorded by ATARA BIOTHERAPEUTICS INC in the same timeframe -4085.62%

ATARA BIOTHERAPEUTICS INC's ROE vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROE Benchmarks
CompanyROE
IGMS : IGM BIOSCIENCES INC -52.89%STRO : SUTRO BIOPHARMA INC -MGNX : MACROGENICS INC -78.08%CHRS : COHERUS ONCOLOGY INC 150.01%IPSC : CENTURY THERAPEUTICS INC -11.09%KPTI : KARYOPHARM THERAPEUTICS INC -DOMH : DOMINARI HOLDINGS INC -21.72%MGX : METAGENOMI INC -44.49%FBIO : FORTRESS BIOTECH INC -54.76%ZYXI : ZYNEX INC -2272.96%

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for ATARA BIOTHERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -303.81M ] / Equity [ $ 353.94M ]
(=) ROE [ -85.84% ]

ATRA - Return on Equity, Last 5 years

-4085.62%

Minimum

Jun 30, 2023

-66.32%

Maximum

Dec 31, 2020

-461.21%

Average

-113.72%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.14K
min-66.79%
max73.25%
average1.51%
median6.45%
std22.67%